Related Experiment Video
Updated: Aug 16, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
[Differentiation-inducing effects of perphenazine on K562 leukemia cells]
1Research Laboratory of Blood Physiology, Xiangya School of Medicine, Central South University, Changsha 410078, China.
Objective:
To determine the differentiation-inducing effects of perphenazine on K562 leukemia cells.
Methods:
Differentiation-Inducing effects of a phenothiazine perphenazine were evaluated by proliferation, morphology and function of K562 cells. We evaluated the effects of perphenazine on K562 cells proliferation by cellular enumeration in liquid culture assay, MTT assay and clony formation assay, the morphology by Wight-Gimesa staining, and the function by detecting CD71 through flow cytometry.
Results:
Perphenazine enhanced the expression of CD71 on K562 cells and increased Hb content in K562 cells, while inhibited the proliferation of K562 cells. K562 cells showed differentiation morphology after the drug treatment.
Conclusion:
Perphenazine possessed differentiation-inducing effects on K562 cells.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Differentiation of Common Myeloid Progenitor Cells
